The shared phenotypes of aripiprazole and mice with impaired LEP/LEPR function like “obesity”, “insulin resistance” and “glucose tolerance impaired” (Fig 3a) point to alterations of leptinergic signalling by the antipsychotic aripiprazole. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.